Sedation in Cardiogenic Shock

Hemodynamic Considerations

The European Society of Cardiology recommends benzodiazepines like midazolam for sedation in patients with severe left ventricular dysfunction, large areas of ischemia, or acute heart failure due to their safer cardiovascular stability compared to propofol 1, 2
Midazolam is preferred over propofol for sedation in patients with cardiogenic shock due to its more favorable hemodynamic profile in severe cardiac dysfunction 3, 1
Propofol causes dose-dependent decreases in blood pressure and heart rate, which can exacerbate hemodynamic instability in cardiogenic shock, and has raised safety concerns during bradyarrhythmias 4

For patients requiring deep sedation, the European Heart Journal suggests beginning with opiates (e.g., fentanyl) for analgesia and initial sedation, and adding midazolam as the adjunctive sedative for patients with cardiogenic shock 3, 1, 4

The European Heart Journal notes that dexmedetomidine may be useful during weaning from mechanical ventilation but can aggravate hemodynamic compromise in cardiogenic shock, and ketamine could be reasonable for patients with shock but can suppress myocardial contractility in patients with depleted catecholamine reserves 5

The European Society of Cardiology recommends starting with lower doses of midazolam in patients with hemodynamic instability and titrating carefully 6
Benzodiazepines, such as midazolam, may offer a more favorable hemodynamic profile compared to propofol in patients with severe cardiac dysfunction, according to the European Heart Journal 6, 7
Dexmedetomidine may be useful during weaning from mechanical ventilation in post-cardiac arrest patients, as suggested by the European Heart Journal 6
Ketamine may be considered for patients with hemodynamic instability, but it can suppress myocardial contractility in patients with depleted catecholamine reserves, as noted by the European Heart Journal 6